Skip to main content
. 2015 Jun;62(6):1398–1404. doi: 10.1016/j.jhep.2014.12.034

Fig. 2.

Fig. 2

UDCA increases hepatic triglyceride formation and modulates hepatic SCD expression. (A) Hepatic cholesterol and (B) triglyceride concentrations. (C) Hepatic mRNA expression analysis of markers of lipid metabolism in morbidly obese NAFLD patients. Control: n = 18; UDCA: n = 19. (D) Representative Western blot and densitometry (all samples) of hepatic SCD relative to β-actin. Control: n = 7; UDCA: n = 6. (E) mRNA expression of APOB and MTTP in NAFLD patients. Control: n = 18; UDCA: n = 19. Mean values ± SD are expressed for all data. ∗p ⩽0.05, ∗∗p ⩽0.01 vs. control group.